NERIDERM Cream / Ointment Ref.[8329] Active ingredients: Diflucortolone

Adults

Initially, Neriderm should be applied thinly twice daily. When the condition improves or when longer periods of treatment are required one application daily is appropriate.

Long-term continuous therapy with topical corticosteroids should be avoided, with a usual maximum duration of 4 weeks. If used on the face, courses should be limited to 5 days and occlusion should not be used (see section 4.4).

Children 1-4years of age

Neriderm should be applied thinly twice daily. It should be used with great care, for short periods and generally only on the advice of a doctor specialising in dermatology. Courses should be limited to 5 days and occlusion should not be used.

Children 5 years of age and over

Initially, Neriderm should be applied thinly twice daily. When the condition improves one application daily is appropriate.

Courses should be limited to 1-2 weeks. If used on the face, courses should be limited to 5 days and occlusion should not be used.

Neriderm should not be used in children under 1 year of age.

Elderly

Natural thinning of the skin occurs in the elderly. No special precautions are required, however, when Neriderm is used in this group of patients.

Occlusive dressings

An occlusive dressing may be called for in unusually refractory cases and usually under specialist supervision. If an infection develops under the dressing, occlusive treatment must be terminated. Neriderm Cream is suitable for weeping skin conditions. Neriderm Cream has a high water and low fat content. In weeping skin diseases it allows secretions to drain away, thus providing for rapid reduction of swelling and drying up of the skin. Neriderm Cream is also suitable for application to moist, exposed and hairy areas of the body.

Neriderm Ointment is suitable in very dry skin conditions which need an anhydrous fatty base. The occlusive effect of the Neriderm Ointment base promotes the healing process.

If the skin dries out too much under protracted use of Neriderm Cream, the patient should be switched to a form which contains more fat (Neriderm Ointment).

On the basis of results from acute toxicity studies with both diflucortolone valerate and Neriderm preparations, no acute risk of intoxication is to be expected either after a single dermal application of an overdose (application over a large area under conditions favouring resorption) or even after inadvertent oral intake of a whole tube.

5 years.

Store in a cold place, below 25°C.

Aluminium tubes containing 30g cream or ointment.

Keep out of reach of children.